Study on oral syrup of extract Cichorium intybus root on decreasing liver enzymes in thalassemia patients in Mohammad Kermanshahi hospital of Kermanshah city.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111001007677N6

Enrollment

100

Registered

2020-02-13

Start date

2020-01-20

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thalassemia disease. Thalassemia

Interventions

Intervention 1: Intervention group: Patients will receive chicory extract as a medicinal supplement. The amount of chicory extract will be evaluated based on the BMI of the patients. Gram will be admi

Eligibility

Sex/Gender

All

Age

2 Years to No maximum

Inclusion criteria

Inclusion criteria: major and intermediate thalassemic pations with abnormal AST and ALT

Exclusion criteria

Exclusion criteria: liver failure viral hepatitis ferritin level more than 3000

Design outcomes

Primary

Measure	Time frame
Aspartate aminotransferase. Timepoint: At baseline, one and a half months later, three months later, six months later. Method of measurement: ELISA method and iranian science antibody kits.;Alanin aminotransferase. Timepoint: At baseline, one and a half months later, three months later, six months later. Method of measurement: ELISA method and iranian science antibody kits.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSevda Khashman

Kermanshah University of Medical Sciences

dr.s.khashman@gmail.com+98 83 3721 8208

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026